Global Paediatric Palliative Care Drugs Market
Global Paediatric Palliative Care Drugs Market

Paediatric Palliative Care Drugs Comprehensive Study by Type (Paracetamol, Ibuprofen, Morphine, Others), Route of Administration (Oral, Topical, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End Use (Hospitals, Home Care, Others) Players and Region - Global Market Outlook to 2026

Paediatric Palliative Care Drugs Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Mar 2021 Edition 216 Pages 216 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Paediatric Palliative Care Drugs Market Scope
Paediatric palliative care is a specialized medical care for infants and children living with serious medical conditions such as cancer, genetic disorders, prematurity, heart and lung conditions, neurologic disorders, and others. The palliative care is mainly focus on to improve quality of life for paediatric by providing relief from the symptoms and illness. Paediatric palliative care is specialized medical care given for paediatric wellbeing. Such types of care is focused on delivering relief from the illness. It is mainly focus on to improve the quality of life for both the patient and the family. Palliative care is provided by the team of doctors which are specially-trained, also other specialists, and nurses who work together with a patientís other doctors to provide an extra support. Palliative care is basically based on the needs of the patient, not on the patientís prognosis. Basically it is suitable at any age and at any stage in a illness, and it can be issue along with curative treatment.

The Paediatric Palliative Care Drugs market study is segmented by Type (Paracetamol, Ibuprofen, Morphine and Others) and major geographies with country level break-up.

With the changing landscape, more and more companies are going in for non-linear growth models. The market is also being driven through mergers & acquisitions undertaken by key players, which, when combined with various services, can increase the overall revenue of the market. Research Analyst at AMA estimates that Chinese Players will contribute to the maximum growth of Global Paediatric Palliative Care Drugs market throughout the predicted period.

Mallinckrodt Pharmaceuticals (United Kingdom), Anqiu Lu'an (China), Granules India (India), Zhejiang Kangle (China), Farmson (India), Hebei Jiheng (China), Novacyl (France), Anhui BBCA Likang (China), Anhui Fubore (China) and Atabay (Turkey) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Huzhou Konch and Changshu Huagang.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Paediatric Palliative Care Drugs market by Type, Application and Region.

On the basis of geography, the market of Paediatric Palliative Care Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Market Trend
  • Rising Investment in Healthcare

Market Drivers
  • Increasing Number of Rare Diseases with Paediatric Onset
  • Increasing Paediatric Drugs Product Approvals by Regulatory Authorities

Opportunities
  • Growing Number of Palliative Care Centres Worldwide
  • Increasing Number of Qualified Physicians for Palliative Care Centre

Restraints
  • Lack of Awareness About Palliative Care

Challenges
  • Stringent Government Regulations for Approval of Certain Drugs


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Paediatric Palliative Care Drugs Provider, Hospitals and Clinics, Potential Investors and Others

Frequently asked questions:
1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Paediatric Palliative Care Drugs Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Report Objectives / Segmentation Covered
By Type
  • Paracetamol
  • Ibuprofen
  • Morphine
  • Others
By Route of Administration
  • Oral
  • Topical
  • Parenteral

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By End Use
  • Hospitals
  • Home Care
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Rare Diseases with Paediatric Onset
      • 3.2.2. Increasing Paediatric Drugs Product Approvals by Regulatory Authorities
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Regulations for Approval of Certain Drugs
    • 3.4. Market Trends
      • 3.4.1. Rising Investment in Healthcare
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Paediatric Palliative Care Drugs, by Type, Route of Administration, Distribution Channel, End Use and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Paediatric Palliative Care Drugs (Value)
      • 5.2.1. Global Paediatric Palliative Care Drugs by: Type (Value)
        • 5.2.1.1. Paracetamol
        • 5.2.1.2. Ibuprofen
        • 5.2.1.3. Morphine
        • 5.2.1.4. Others
      • 5.2.2. Global Paediatric Palliative Care Drugs by: Route of Administration (Value)
        • 5.2.2.1. Oral
        • 5.2.2.2. Topical
        • 5.2.2.3. Parenteral
      • 5.2.3. Global Paediatric Palliative Care Drugs by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Online Pharmacies
      • 5.2.4. Global Paediatric Palliative Care Drugs by: End Use (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Home Care
        • 5.2.4.3. Others
      • 5.2.5. Global Paediatric Palliative Care Drugs Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Paediatric Palliative Care Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Mallinckrodt Pharmaceuticals (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Anqiu Lu'an (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Granules India (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Zhejiang Kangle (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Farmson (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Hebei Jiheng (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novacyl (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Anhui BBCA Likang (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Anhui Fubore (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Atabay (Turkey)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Paediatric Palliative Care Drugs Sale, by Type, Route of Administration, Distribution Channel, End Use and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Paediatric Palliative Care Drugs (Value)
      • 7.2.1. Global Paediatric Palliative Care Drugs by: Type (Value)
        • 7.2.1.1. Paracetamol
        • 7.2.1.2. Ibuprofen
        • 7.2.1.3. Morphine
        • 7.2.1.4. Others
      • 7.2.2. Global Paediatric Palliative Care Drugs by: Route of Administration (Value)
        • 7.2.2.1. Oral
        • 7.2.2.2. Topical
        • 7.2.2.3. Parenteral
      • 7.2.3. Global Paediatric Palliative Care Drugs by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Online Pharmacies
      • 7.2.4. Global Paediatric Palliative Care Drugs by: End Use (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Home Care
        • 7.2.4.3. Others
      • 7.2.5. Global Paediatric Palliative Care Drugs Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Paediatric Palliative Care Drugs: by Type(USD Million)
  • Table 2. Paediatric Palliative Care Drugs Paracetamol , by Region USD Million (2015-2020)
  • Table 3. Paediatric Palliative Care Drugs Ibuprofen , by Region USD Million (2015-2020)
  • Table 4. Paediatric Palliative Care Drugs Morphine , by Region USD Million (2015-2020)
  • Table 5. Paediatric Palliative Care Drugs Others , by Region USD Million (2015-2020)
  • Table 6. Paediatric Palliative Care Drugs: by Route of Administration(USD Million)
  • Table 7. Paediatric Palliative Care Drugs Oral , by Region USD Million (2015-2020)
  • Table 8. Paediatric Palliative Care Drugs Topical , by Region USD Million (2015-2020)
  • Table 9. Paediatric Palliative Care Drugs Parenteral , by Region USD Million (2015-2020)
  • Table 10. Paediatric Palliative Care Drugs: by Distribution Channel(USD Million)
  • Table 11. Paediatric Palliative Care Drugs Hospital Pharmacies , by Region USD Million (2015-2020)
  • Table 12. Paediatric Palliative Care Drugs Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 13. Paediatric Palliative Care Drugs Online Pharmacies , by Region USD Million (2015-2020)
  • Table 14. Paediatric Palliative Care Drugs: by End Use(USD Million)
  • Table 15. Paediatric Palliative Care Drugs Hospitals , by Region USD Million (2015-2020)
  • Table 16. Paediatric Palliative Care Drugs Home Care , by Region USD Million (2015-2020)
  • Table 17. Paediatric Palliative Care Drugs Others , by Region USD Million (2015-2020)
  • Table 18. South America Paediatric Palliative Care Drugs, by Country USD Million (2015-2020)
  • Table 19. South America Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 20. South America Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 21. South America Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 22. South America Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 23. Brazil Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 24. Brazil Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 25. Brazil Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 26. Brazil Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 27. Argentina Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 28. Argentina Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 29. Argentina Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 30. Argentina Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 31. Rest of South America Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 32. Rest of South America Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 33. Rest of South America Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 34. Rest of South America Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 35. Asia Pacific Paediatric Palliative Care Drugs, by Country USD Million (2015-2020)
  • Table 36. Asia Pacific Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 37. Asia Pacific Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 38. Asia Pacific Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 39. Asia Pacific Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 40. China Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 41. China Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 42. China Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 43. China Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 44. Japan Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 45. Japan Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 46. Japan Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 47. Japan Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 48. India Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 49. India Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 50. India Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 51. India Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 52. South Korea Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 53. South Korea Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 54. South Korea Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 55. South Korea Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 56. Taiwan Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 57. Taiwan Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 58. Taiwan Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 59. Taiwan Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 60. Australia Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 61. Australia Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 62. Australia Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 63. Australia Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 65. Rest of Asia-Pacific Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 66. Rest of Asia-Pacific Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 68. Europe Paediatric Palliative Care Drugs, by Country USD Million (2015-2020)
  • Table 69. Europe Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 70. Europe Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 71. Europe Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 72. Europe Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 73. Germany Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 74. Germany Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 75. Germany Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 76. Germany Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 77. France Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 78. France Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 79. France Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 80. France Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 81. Italy Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 82. Italy Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 83. Italy Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 84. Italy Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 85. United Kingdom Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 86. United Kingdom Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 87. United Kingdom Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 88. United Kingdom Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 89. Netherlands Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 90. Netherlands Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 91. Netherlands Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 92. Netherlands Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 93. Rest of Europe Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 94. Rest of Europe Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 95. Rest of Europe Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 96. Rest of Europe Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 97. MEA Paediatric Palliative Care Drugs, by Country USD Million (2015-2020)
  • Table 98. MEA Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 99. MEA Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 100. MEA Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 101. MEA Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 102. Middle East Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 103. Middle East Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 104. Middle East Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 105. Middle East Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 106. Africa Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 107. Africa Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 108. Africa Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 109. Africa Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 110. North America Paediatric Palliative Care Drugs, by Country USD Million (2015-2020)
  • Table 111. North America Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 112. North America Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 113. North America Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 114. North America Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 115. United States Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 116. United States Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 117. United States Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 118. United States Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 119. Canada Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 120. Canada Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 121. Canada Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 122. Canada Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 123. Mexico Paediatric Palliative Care Drugs, by Type USD Million (2015-2020)
  • Table 124. Mexico Paediatric Palliative Care Drugs, by Route of Administration USD Million (2015-2020)
  • Table 125. Mexico Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 126. Mexico Paediatric Palliative Care Drugs, by End Use USD Million (2015-2020)
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Paediatric Palliative Care Drugs: by Type(USD Million)
  • Table 138. Paediatric Palliative Care Drugs Paracetamol , by Region USD Million (2021-2026)
  • Table 139. Paediatric Palliative Care Drugs Ibuprofen , by Region USD Million (2021-2026)
  • Table 140. Paediatric Palliative Care Drugs Morphine , by Region USD Million (2021-2026)
  • Table 141. Paediatric Palliative Care Drugs Others , by Region USD Million (2021-2026)
  • Table 142. Paediatric Palliative Care Drugs: by Route of Administration(USD Million)
  • Table 143. Paediatric Palliative Care Drugs Oral , by Region USD Million (2021-2026)
  • Table 144. Paediatric Palliative Care Drugs Topical , by Region USD Million (2021-2026)
  • Table 145. Paediatric Palliative Care Drugs Parenteral , by Region USD Million (2021-2026)
  • Table 146. Paediatric Palliative Care Drugs: by Distribution Channel(USD Million)
  • Table 147. Paediatric Palliative Care Drugs Hospital Pharmacies , by Region USD Million (2021-2026)
  • Table 148. Paediatric Palliative Care Drugs Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 149. Paediatric Palliative Care Drugs Online Pharmacies , by Region USD Million (2021-2026)
  • Table 150. Paediatric Palliative Care Drugs: by End Use(USD Million)
  • Table 151. Paediatric Palliative Care Drugs Hospitals , by Region USD Million (2021-2026)
  • Table 152. Paediatric Palliative Care Drugs Home Care , by Region USD Million (2021-2026)
  • Table 153. Paediatric Palliative Care Drugs Others , by Region USD Million (2021-2026)
  • Table 154. South America Paediatric Palliative Care Drugs, by Country USD Million (2021-2026)
  • Table 155. South America Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 156. South America Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 157. South America Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 158. South America Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 159. Brazil Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 160. Brazil Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 161. Brazil Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 162. Brazil Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 163. Argentina Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 164. Argentina Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 165. Argentina Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 166. Argentina Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 167. Rest of South America Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 168. Rest of South America Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 169. Rest of South America Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 170. Rest of South America Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 171. Asia Pacific Paediatric Palliative Care Drugs, by Country USD Million (2021-2026)
  • Table 172. Asia Pacific Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 173. Asia Pacific Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 174. Asia Pacific Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 175. Asia Pacific Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 176. China Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 177. China Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 178. China Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 179. China Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 180. Japan Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 181. Japan Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 182. Japan Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 183. Japan Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 184. India Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 185. India Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 186. India Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 187. India Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 188. South Korea Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 189. South Korea Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 190. South Korea Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 191. South Korea Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 192. Taiwan Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 193. Taiwan Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 194. Taiwan Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 195. Taiwan Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 196. Australia Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 197. Australia Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 198. Australia Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 199. Australia Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 200. Rest of Asia-Pacific Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 201. Rest of Asia-Pacific Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 202. Rest of Asia-Pacific Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 203. Rest of Asia-Pacific Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 204. Europe Paediatric Palliative Care Drugs, by Country USD Million (2021-2026)
  • Table 205. Europe Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 206. Europe Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 207. Europe Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 208. Europe Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 209. Germany Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 210. Germany Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 211. Germany Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 212. Germany Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 213. France Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 214. France Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 215. France Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 216. France Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 217. Italy Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 218. Italy Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 219. Italy Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 220. Italy Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 221. United Kingdom Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 222. United Kingdom Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 223. United Kingdom Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 224. United Kingdom Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 225. Netherlands Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 226. Netherlands Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 227. Netherlands Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 228. Netherlands Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 229. Rest of Europe Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 230. Rest of Europe Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 231. Rest of Europe Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 232. Rest of Europe Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 233. MEA Paediatric Palliative Care Drugs, by Country USD Million (2021-2026)
  • Table 234. MEA Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 235. MEA Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 236. MEA Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 237. MEA Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 238. Middle East Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 239. Middle East Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 240. Middle East Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 241. Middle East Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 242. Africa Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 243. Africa Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 244. Africa Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 245. Africa Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 246. North America Paediatric Palliative Care Drugs, by Country USD Million (2021-2026)
  • Table 247. North America Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 248. North America Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 249. North America Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 250. North America Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 251. United States Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 252. United States Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 253. United States Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 254. United States Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 255. Canada Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 256. Canada Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 257. Canada Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 258. Canada Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 259. Mexico Paediatric Palliative Care Drugs, by Type USD Million (2021-2026)
  • Table 260. Mexico Paediatric Palliative Care Drugs, by Route of Administration USD Million (2021-2026)
  • Table 261. Mexico Paediatric Palliative Care Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 262. Mexico Paediatric Palliative Care Drugs, by End Use USD Million (2021-2026)
  • Table 263. Research Programs/Design for This Report
  • Table 264. Key Data Information from Secondary Sources
  • Table 265. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Paediatric Palliative Care Drugs: by Type USD Million (2015-2020)
  • Figure 5. Global Paediatric Palliative Care Drugs: by Route of Administration USD Million (2015-2020)
  • Figure 6. Global Paediatric Palliative Care Drugs: by Distribution Channel USD Million (2015-2020)
  • Figure 7. Global Paediatric Palliative Care Drugs: by End Use USD Million (2015-2020)
  • Figure 8. South America Paediatric Palliative Care Drugs Share (%), by Country
  • Figure 9. Asia Pacific Paediatric Palliative Care Drugs Share (%), by Country
  • Figure 10. Europe Paediatric Palliative Care Drugs Share (%), by Country
  • Figure 11. MEA Paediatric Palliative Care Drugs Share (%), by Country
  • Figure 12. North America Paediatric Palliative Care Drugs Share (%), by Country
  • Figure 13. Global Paediatric Palliative Care Drugs share by Players 2020 (%)
  • Figure 14. Global Paediatric Palliative Care Drugs share by Players (Top 3) 2020(%)
  • Figure 15. Global Paediatric Palliative Care Drugs share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Mallinckrodt Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 18. Mallinckrodt Pharmaceuticals (United Kingdom) Revenue: by Geography 2020
  • Figure 19. Anqiu Lu'an (China) Revenue, Net Income and Gross profit
  • Figure 20. Anqiu Lu'an (China) Revenue: by Geography 2020
  • Figure 21. Granules India (India) Revenue, Net Income and Gross profit
  • Figure 22. Granules India (India) Revenue: by Geography 2020
  • Figure 23. Zhejiang Kangle (China) Revenue, Net Income and Gross profit
  • Figure 24. Zhejiang Kangle (China) Revenue: by Geography 2020
  • Figure 25. Farmson (India) Revenue, Net Income and Gross profit
  • Figure 26. Farmson (India) Revenue: by Geography 2020
  • Figure 27. Hebei Jiheng (China) Revenue, Net Income and Gross profit
  • Figure 28. Hebei Jiheng (China) Revenue: by Geography 2020
  • Figure 29. Novacyl (France) Revenue, Net Income and Gross profit
  • Figure 30. Novacyl (France) Revenue: by Geography 2020
  • Figure 31. Anhui BBCA Likang (China) Revenue, Net Income and Gross profit
  • Figure 32. Anhui BBCA Likang (China) Revenue: by Geography 2020
  • Figure 33. Anhui Fubore (China) Revenue, Net Income and Gross profit
  • Figure 34. Anhui Fubore (China) Revenue: by Geography 2020
  • Figure 35. Atabay (Turkey) Revenue, Net Income and Gross profit
  • Figure 36. Atabay (Turkey) Revenue: by Geography 2020
  • Figure 37. Global Paediatric Palliative Care Drugs: by Type USD Million (2021-2026)
  • Figure 38. Global Paediatric Palliative Care Drugs: by Route of Administration USD Million (2021-2026)
  • Figure 39. Global Paediatric Palliative Care Drugs: by Distribution Channel USD Million (2021-2026)
  • Figure 40. Global Paediatric Palliative Care Drugs: by End Use USD Million (2021-2026)
  • Figure 41. South America Paediatric Palliative Care Drugs Share (%), by Country
  • Figure 42. Asia Pacific Paediatric Palliative Care Drugs Share (%), by Country
  • Figure 43. Europe Paediatric Palliative Care Drugs Share (%), by Country
  • Figure 44. MEA Paediatric Palliative Care Drugs Share (%), by Country
  • Figure 45. North America Paediatric Palliative Care Drugs Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Mallinckrodt Pharmaceuticals (United Kingdom)
  • Anqiu Lu'an (China)
  • Granules India (India)
  • Zhejiang Kangle (China)
  • Farmson (India)
  • Hebei Jiheng (China)
  • Novacyl (France)
  • Anhui BBCA Likang (China)
  • Anhui Fubore (China)
  • Atabay (Turkey)
Additional players considered in the study are as follows:
Huzhou Konch , Changshu Huagang
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation